1 6662 97 UPREGULATION OF FZD5 IN EOSINOPHILIC CHRONIC RHINOSINUSITIS WITH NASAL POLYPS BY EPIGENETIC MODIFICATION. EOSINOPHILIC CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) IS ONE OF THE MOST CHALLENGING PROBLEMS IN CLINICAL RHINOLOGY. FZD5 IS A RECEPTOR FOR WNT5A, AND ITS COMPLEX WITH WNT5A CONTRIBUTES TO ACTIVATING INFLAMMATION AND TISSUE MODIFICATION. NASAL POLYPS AND EOSINOPHIL/NON-EOSINOPHIL COUNTS ARE REPORTED TO BE DIRECTLY CORRELATED. THIS STUDY INVESTIGATED THE EXPRESSION AND DISTRIBUTION OF FZD5, AND THE ROLE OF EOSINOPHIL INFILTRATION AND FZD5 IN EOSINOPHILIC CRSWNP PATHOGENESIS. THE PROGNOSTIC ROLE OF EOSINOPHIL LEVELS WAS EVALUATED IN SEVEN PATIENTS WITH CRSWNP. FIFTEEN PATIENTS WITH CRS WERE CLASSIFIED BASED ON THE PERCENTAGE OF EOSINOPHILS IN NASAL POLYP TISSUE. METHYLATED GENES WERE DETECTED USING METHYL-CPG-BINDING DOMAIN SEQUENCING, AND QRT-PCR AND IMMUNOHISTOCHEMISTRY WERE USED TO DETECT FZD5 EXPRESSION IN NASAL POLYP TISSUE SAMPLES. THE RESULTS SHOWED THAT MRNA EXPRESSION OF FZD5 WAS UPREGULATED IN NASAL POLYPS. FZD5 EXPRESSION WAS SIGNIFICANTLY HIGHER IN NASAL POLYP SAMPLES FROM PATIENTS WITH EOSINOPHILIC CRSWNP THAN IN THOSE FROM PATIENTS WITH NON-EOSINOPHILIC CRSWNP, AS INDICATED BY IMMUNOHISTOCHEMISTRY. FURTHERMORE, INFLAMMATORY CYTOKINE LEVELS WERE HIGHER IN EOSINOPHILIC CRSWNP-DERIVED EPITHELIAL CELLS THAN IN NORMAL TISSUES. IN CONCLUSION, FZD5 EXPRESSION IN NASAL MUCOSAL EPITHELIAL CELLS IS CORRELATED WITH INFLAMMATORY CELLS AND MIGHT PLAY A ROLE IN THE PATHOGENESIS OF EOSINOPHILIC CRSWNP. 2019 2 5553 44 ROLE OF EPIGENETICS IN THE PATHOGENESIS OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. CHRONIC RHINOSINUSITIS (CRS) IS A HIGHLY PREVALENT DISEASE CHARACTERIZED BY MUCOSAL INFLAMMATION OF THE NOSE AND PARANASAL SINUSES. CRS CAN BE DIVIDED INTO TWO MAIN CATEGORIES, CRS WITH NASAL POLYPS (NPS; CRSWNP) AND CRS WITHOUT NPS (CRSSNP). ALTHOUGH THE PATHOPHYSIOLOGY OF CRS REMAINS UNCLEAR, DNA METHYLATION HAS BEEN IMPLICATED IN THE ETIOLOGY OF CRSWNP. THE AIM OF THE PRESENT STUDY WAS TO ELUCIDATE WHETHER DNA METHYLATION OF SPECIFIC GENES IS INVOLVED IN THE DEVELOPMENT OF NPS. IN TOTAL, 18 INDIVIDUALS WERE INCLUDED IN THE PRESENT STUDY, AND WERE DIVIDED INTO THREE GROUPS: CRSWNP (N=7), CRSSNP (N=7) AND HEALTHY CONTROLS (N=4). NP TISSUES WERE OBTAINED FROM THE SEVEN PATIENTS WITH CRSWNP AND BIOPSIES OF THE INFERIOR TURBINATE MUCOSA FROM ALL THREE GROUPS WERE USED AS CONTROLS. METHYLATED GENES DETECTED BY METHYL?CPG?BINDING DOMAIN SEQUENCING WERE VALIDATED BY METHYLATION?SPECIFIC POLYMERASE CHAIN REACTION (PCR), BISULFITE SEQUENCING, AND REVERSE TRANSCRIPTION?QUANTITATIVE PCR (RT?QPCR). METHYL?CPG?BINDING DOMAIN SEQUENCING IDENTIFIED 43,674 CPG ISLANDS IN 518 GENES. THE PROMOTOR REGIONS OF 10 AND 30 GENES WERE HYPERMETHYLATED AND HYPOMETHYLATED, RESPECTIVELY, IN NP SAMPLES COMPARED WITH CONTROLS. THE TOP FOUR GENES WITH ALTERED HYPOMETHYLATION IN NP TISSUES WERE, KERATIN 19 (KRT19), NUCLEAR RECEPTOR SUBFAMILY 2 GROUP F MEMBER 2 (NR2F2), A DISINTEGRIN?LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH THROMBOSPONDIN TYPE 1 MOTIF 1 (ADAMTS1) AND ZINC FINGER PROTEIN 222 (ZNF222). RT?QPCR DEMONSTRATED THAT THE EXPRESSION LEVELS OF KRT19, NR2F2 AND ADAMTS1 WERE SIGNIFICANTLY INCREASED IN NP TISSUES; HOWEVER, THERE WAS NO DIFFERENCE IN THE LEVELS OF ZNF222 BETWEEN NP AND CONTROL TISSUES. FURTHER STUDIES ARE REQUIRED TO CONFIRM THE RELEVANCE OF THESE EPIGENETIC MODIFICATIONS IN THE MECHANISMS UNDERLYING NP FORMATION. 2018 3 3075 36 GENOME-WIDE EPIGENETIC STUDY OF CHRONIC RHINOSINUSITIS TISSUES REVEALS DYSREGULATED INFLAMMATORY, IMMUNOLOGIC AND REMODELING PATHWAYS. BACKGROUND: EPIGENETICS STUDIES MECHANISMS SUCH AS DNA METHYLATION, HISTONE MODIFICATIONS, NON-CODING RNAS, AND ALTERNATIVE POLYADENYLATION THAT CAN MODIFY GENE ACTIVITY WITHOUT CHANGING THE UNDERLYING DNA NUCLEOTIDE BASE-PAIR STRUCTURE. BECAUSE THESE CHANGES ARE REVERSIBLE, THEY HAVE POTENTIAL IN DEVELOPING NOVEL THERAPEUTICS. CURRENTLY, SEVEN PHARMACEUTICAL AGENTS TARGETING EPIGENETIC CHANGES ARE FDA APPROVED AND COMMERCIALLY AVAILABLE FOR TREATMENT OF CERTAIN CANCERS. HOWEVER, STUDIES INVESTIGATING EPIGENETICS IN CHRONIC RHINOSINUSITIS (CRS) HAVE NOT BEEN UNDERTAKEN PREVIOUSLY IN THE UNITED STATES. OBJECTIVES: THE GOAL OF THIS STUDY WAS TO INVESTIGATE SINONASAL DNA METHYLATION PATTERNS IN CRS VERSUS CONTROLS, TO DISCERN ENVIRONMENTALLY-INDUCED EPIGENETIC CHANGES IMPACTING CRS SUBJECTS. METHODS AND RESULTS: ETHMOIDAL SAMPLES FROM CRS AND INFERIOR TURBINATE MUCOSAL TISSUE SAMPLES FROM CONTROLS WITHOUT CRS WERE STUDIED. DNA METHYLATION WAS STUDIED BY REDUCED REPRESENTATION BISULFITE SEQUENCING. RADMETH(R) BIOSTATISTICAL PACKAGE WAS USED TO IDENTIFY DIFFERENTIALLY METHYLATED REGIONS (DMRS) BETWEEN CRS AND CONTROLS. INGENUITY PATHWAY ANALYSIS OF DMRS WAS PERFORMED TO IDENTIFY TOP UPSTREAM REGULATORS AND CANONICAL PATHWAYS. NINETY-THREE SAMPLES FROM 64 CRS SUBJECTS (36 CRSWNP; 28 CRSSNP) AND 29 CONTROLS WERE STUDIED. CRS AND CONTROL SAMPLES DIFFERED IN 13 662 CPGS SITES AND 1381 DMRS. TOP UPSTREAM REGULATORS IDENTIFIED INCLUDED: 1. CRS VERSUS CONTROLS: TGFB1, TNF, TP53, DGCR8, AND BETA-ESTRADIOL. 2. CRSWNP VERSUS CONTROLS: TGFB1, CTNNB1, LIPOPOLYSACCHARIDE, ID2, AND TCF7L2. 3. CRSSNP VERSUS CONTROLS: MYOD1, ACETONE, ID2, ST8SIA4, AND LEPR. CONCLUSIONS: DIFFERENTIAL PATTERNS OF METHYLATION WERE IDENTIFIED BETWEEN CONTROLS AND CRS, CRSWNP, AND CRSSNP. EPIGENETIC, ENVIRONMENTALLY-INDUCED CHANGES RELATED TO NOVEL, INFLAMMATORY, IMMUNOLOGIC, AND REMODELING PATHWAYS APPEAR TO AFFECT EPITHELIAL INTEGRITY, CELL PROLIFERATION, HOMEOSTASIS, VASCULAR PERMEABILITY, AND OTHER YET UNCHARACTERIZED PATHWAYS AND GENES. 2023 4 3460 40 HYPOMETHYLATION OF THE IL8 PROMOTER IN NASAL EPITHELIAL CELLS OF PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. BACKGROUND: IL-8 IS AN IMPORTANT CHEMOKINE IMPLICATED IN THE PATHOGENESIS OF CHRONIC RHINOSINUSITIS (CRS), BUT LITTLE IS KNOWN ABOUT EPIGENETIC REGULATION OF IL8 IN THE PATHOGENESIS OF CRS. OBJECTIVE: WE SOUGHT TO INVESTIGATE THE RELATIONSHIP BETWEEN THE DNA METHYLATION LEVEL IN THE IL8 PROXIMAL PROMOTER AND CRS IN HAN CHINESE SUBJECTS. METHODS: PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP; N = 187), PATIENTS WITH CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS (CRSSNP; N = 89), AND CONTROL SUBJECTS (N = 57) WERE ENROLLED IN 2 INDEPENDENT COHORTS. PURIFIED HUMAN NASAL EPITHELIAL CELLS FROM EACH PARTICIPANT WERE ASSESSED FOR PERCENTAGE DNA METHYLATION OF CPG SITES IN THE IL8 PROXIMAL PROMOTER BY USING BISULFITE PYROSEQUENCING AND FOR FUNCTIONAL ASPECTS OF METHYLATION STATUS BY USING IN VITRO ASSAYS. RESULTS: DNA METHYLATION OF CPG SITES 1, 2, AND 3, RESPECTIVELY, IN THE IL8 PROXIMAL PROMOTER WAS SIGNIFICANTLY DECREASED IN HUMAN NASAL EPITHELIAL CELLS OF PATIENTS WITH CRSWNP COMPARED WITH THAT IN PATIENTS WITH CRSSNP (P < .001) AND CONTROL SUBJECTS (P < .001). PERCENTAGE OF DNA METHYLATION OF THE CPG3 SITE WAS CORRELATED NEGATIVELY WITH BOTH TISSUE EOSINOPHILIC CATIONIC PROTEIN (P < .01) AND MYELOPEROXIDASE (P < .05) LEVELS. IL-1BETA (P < .001) AND TNF-ALPHA (P < .01) SIGNIFICANTLY INCREASED IL8 EXPRESSION ACCOMPANIED BY A REDUCTION IN METHYLATION AT THE CPG3 SITE (P < .001). ELECTROPHORETIC MOBILITY SHIFT ASSAYS DEMONSTRATED THAT METHYLATION STATUS OF CPG3 CHANGED THE BINDING OF OCTAMER-BINDING TRANSCRIPTION FACTOR 1 AND NUCLEAR FACTOR KAPPAB. CONCLUSION: DECREASED DNA METHYLATION OF PARTICULARLY CPG SITES IN THE IL8 PROXIMAL PROMOTER MIGHT PLAY A ROLE IN THE PATHOGENESIS OF CRSWNP. 2019 5 6349 30 THE ROLE OF EPIGENETICS IN THE CHRONIC SINUSITIS WITH NASAL POLYP. PURPOSE OF REVIEW: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) IS A COMMON AND HETEROGENEOUS INFLAMMATORY DISEASE. THE UNDERLYING EPIGENETIC MECHANISMS AND TREATMENT OF CRSWNP ARE PARTIALLY UNDERSTOOD. OF THE DIFFERENT EPIGENETIC CHANGES IN CRSWNP, HISTONE DEACETYLASES (HDACS), METHYLATION OF DNA, AND THE LEVELS OF MIRNA ARE WIDELY STUDIED. HERE, WE REVIEW THE HUMAN STUDIES OF EPIGENETIC MECHANISMS IN CRSWNP. RECENT FINDINGS: THE PROMOTERS OF COL18A1, PTGES, PLAT, AND TSLP GENES ARE HYPERMETHYLATED IN CRSWNP COMPARED WITH THOSE OF CONTROLS, WHILE THE PROMOTERS OF PGDS, ALOX5AP, LTB4R, IL-8, AND FZD5 GENES ARE HYPOMETHYLATED IN CRSWNP. PROMOTER HYPERMETHYLATION SUPPRESSES THE GENE EXPRESSION, WHILE PROMOTER HYPOMETHYLATION INCREASES THE GENE EXPRESSION. STUDIES HAVE SHOWN THE ELEVATION IN THE LEVELS OF HDAC2, HDAC4, AND H3K4ME3 IN CRSWNP. IN CRSWNP PATIENTS, THERE IS ALSO AN UPREGULATION OF CERTAIN MIRNAS INCLUDING MIR-125B, MIR-155, MIR-19A, MIR-142-3P, AND MIR-21 AND DOWNREGULATION OF MIR-4492. EPIGENETICS TAKES PART IN THE IMMUNOLOGY OF CRSWNP AND MAY GIVE RISE TO ENDOTYPES OF CRSWNP. BOTH HDAC2 AND THE MIRNA INCLUDING MIR-18A, MIR-124A, AND MIR-142-3P MAY TAKE FUNCTION IN THE REGULATION OF GLUCOCORTICOID RESISTANCE. HDAC INHIBITORS AND KDM2B HAVE SHOWN EFFECTIVENESS IN DECREASING NASAL POLYP, AND DNA METHYLTRANSFERASE (DNMT) OR HDAC INHIBITORS MAY HAVE A POTENTIAL EFFICACY FOR THE TREATMENT OF CRSWNP. RECENT ADVANCES IN THE EPIGENETICS OF CRSWNP HAVE LED TO THE IDENTIFICATION OF SEVERAL POTENTIAL THERAPEUTIC TARGETS FOR THIS DISEASE. THE USE OF EPIGENETICS MAY PROVIDE NOVEL AND EFFECTIVE BIOMARKERS AND THERAPIES FOR THE TREATMENT OF NASAL POLYP. 2020 6 1564 36 DNA METHYLATION OF PROXIMAL PLAT PROMOTER IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. BACKGROUND NASAL POLYPS (NP) ARE CHARACTERIZED BY PSEUDOCYSTS DERIVED FROM STROMAL TISSUE EDEMA AND CAUSE PERSISTENT INFECTIONS IN PATIENTS WITH CHRONIC RHINOSINUSITIS (CRS). A LOW LEVEL OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (GENE NAME PLAT) IS CONSIDERED A CAUSE OF STROMAL TISSUE EDEMA BECAUSE OF INSUFFICIENT PLASMIN ACTIVATION IN NP; HOWEVER, THE MECHANISM REGULATING PLAT GENE EXPRESSION LEVELS IS STILL UNCLEAR. THE EPIGENETIC MECHANISM REGULATING THE PLAT GENE EXPRESSION HAS BEEN STUDIED IN OTHER TISSUES. OBJECTIVE WE AIMED TO INVESTIGATE THE METHYLATION LEVELS IN THE PROXIMAL PLAT PROMOTER AND THEIR EFFECTS ON GENE EXPRESSION IN NP TISSUE. METHODS WE INVESTIGATED THE METHYLATION LEVELS AT 3 CPG SITES IN THE PROXIMAL PLAT PROMOTER REGIONS (-618, -121, AND -105 WITH RESPECT TO THE TRANSCRIPTION INITIATION SITE) BY BISULFITE PYROSEQUENCING AND THEIR EFFECTS ON THE GENE EXPRESSION BY QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION (QPCR) IN 20 PAIRED SAMPLES OF NP AND INFERIOR TURBINATE TISSUE (IT) FROM PATIENTS WITH CRS. RESULTS THE DNA METHYLATION LEVELS AT ALL CPG SITES WERE HIGHER ( P < .01), AND THE PLAT EXPRESSION WAS LOWER ( P < .001) IN NP COMPARED WITH IT. THE METHYLATION CHANGES AT THE -618 SITE SHOWED A NEGATIVE CORRELATION WITH THE GENE EXPRESSION CHANGES BETWEEN NP AND IT ( R = -.65, P < .01). CONCLUSIONS HYPERMETHYLATION OF PLAT PROMOTER MAY DOWNREGULATE THE GENE EXPRESSION IN NP, LEADING TO EXCESSIVE FIBRIN DEPOSITION BY ABERRANT COAGULATION CASCADE. DNA METHYLATION OF PROXIMAL PLAT PROMOTER MAY CONTRIBUTE TO NP GROWTH AND HAVE A POTENTIAL AS A NEW THERAPEUTIC TARGET. 2018 7 2406 39 EPIGENETIC RESPONSES TO RHINOVIRUS EXPOSURE IN AIRWAY EPITHELIAL CELLS ARE CORRELATED WITH KEY TRANSCRIPTIONAL PATHWAYS IN CHRONIC RHINOSINUSITIS. BACKGROUND: VIRUSES MAY DRIVE IMMUNE MECHANISMS RESPONSIBLE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (CRSWNP), BUT LITTLE IS KNOWN ABOUT THE UNDERLYING MOLECULAR MECHANISMS. OBJECTIVES: TO IDENTIFY EPIGENETIC AND TRANSCRIPTIONAL RESPONSES TO A COMMON UPPER RESPIRATORY PATHOGEN, RHINOVIRUS (RV), THAT ARE SPECIFIC TO PATIENTS WITH CRSWNP USING A PRIMARY SINONASAL EPITHELIAL CELL CULTURE MODEL. METHODS: AIRWAY EPITHELIAL CELLS WERE COLLECTED AT SURGERY FROM PATIENTS WITH CRSWNP (CASES) AND FROM CONTROLS WITHOUT SINUS DISEASE, CULTURED, AND THEN EXPOSED TO RV OR VEHICLE FOR 48 H. DIFFERENTIAL GENE EXPRESSION AND DNA METHYLATION (DNAM) BETWEEN CASES AND CONTROLS IN RESPONSE TO RV WERE DETERMINED USING LINEAR MIXED MODELS. WEIGHTED GENE CO-EXPRESSION ANALYSIS (WGCNA) WAS USED TO IDENTIFY (A) CO-REGULATED GENE EXPRESSION AND DNAM SIGNATURES, AND (B) GENES, PATHWAYS, AND REGULATORY MECHANISMS SPECIFIC TO CRSWNP. RESULTS: WE IDENTIFIED 5585 DIFFERENTIAL TRANSCRIPTIONAL AND 261 DNAM RESPONSES (FDR <0.10) TO RV BETWEEN CRSWNP CASES AND CONTROLS. THESE DIFFERENTIAL RESPONSES FORMED THREE CO-EXPRESSION/CO-METHYLATION MODULES THAT WERE RELATED TO CRSWNP AND THREE THAT WERE RELATED TO RV (BONFERRONI CORRECTED P < .01). MOST (95%) OF THE DIFFERENTIALLY METHYLATED CPGS (DMCS) WERE IN MODULES RELATED TO CRSWNP, WHEREAS THE DIFFERENTIALLY EXPRESSED GENES (DEGS) WERE MORE EQUALLY DISTRIBUTED BETWEEN THE CRSWNP- AND RV-RELATED MODULES. GENES IN THE CRSWNP-RELATED MODULES WERE ENRICHED IN KNOWN CRS AND/OR VIRAL RESPONSE IMMUNE PATHWAYS. CONCLUSION: RV ACTIVATES SPECIFIC EPIGENETIC PROGRAMS AND CORRELATED TRANSCRIPTIONAL NETWORKS IN THE SINONASAL EPITHELIUM OF INDIVIDUALS WITH CRSWNP. THESE NOVEL OBSERVATIONS SUGGEST EPIGENETIC SIGNATURES SPECIFIC TO PATIENTS WITH CRSWNP MODULATE RESPONSE TO VIRAL PATHOGENS AT THE MUCOSAL ENVIRONMENTAL INTERFACE. DETERMINING HOW VIRAL RESPONSE PATHWAYS ARE INVOLVED IN EPITHELIAL INFLAMMATION IN CRSWNP COULD LEAD TO THERAPEUTIC TARGETS FOR THIS BURDENSOME AIRWAY DISORDER. 2023 8 3758 33 INTEGRATED MRNA AND MICRORNA TRANSCRIPTOME PROFILING DURING DIFFERENTIATION OF HUMAN NASAL POLYP EPITHELIUM REVEALS AN ALTERED CILIOGENESIS. BACKGROUND: HUMAN ADULT BASAL STEM/PROGENITOR CELLS (BSCS) OBTAINED FROM CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHEN DIFFERENTIATED IN AN AIR-LIQUID INTERFACE (ALI) USUALLY PROVIDE A PSEUDOSTRATIFIED AIRWAY EPITHELIUM WITH SIMILAR ABNORMALITIES THAN ORIGINAL IN VIVO PHENOTYPE. HOWEVER, THE INTRINSIC MECHANISMS REGULATING THIS COMPLEX PROCESS ARE NOT WELL DEFINED AND THEIR UNDERSTANDING COULD OFFER POTENTIAL NEW THERAPIES FOR CRSWNP (INCURABLE DISEASE). METHODS: WE PERFORMED A TRANSCRIPTOME-WIDE ANALYSIS DURING IN VITRO MUCOCILIARY DIFFERENTIATION OF HUMAN ADULT BSCS FROM CRSWNP, COMPARED TO THOSE ISOLATED FROM CONTROL NASAL MUCOSA (CONTROL-NM), IN ORDER TO IDENTIFY WHICH KEY MRNA AND MICRORNAS ARE REGULATING THIS COMPLEX PROCESS IN PATHOLOGICAL AND HEALTHY CONDITIONS. RESULTS: A NUMBER OF GENES, MIRS, BIOLOGICAL PROCESSES, AND PATHWAYS WERE IDENTIFIED DURING MUCOCILIARY DIFFERENTIATION OF BOTH CRSWNP AND CONTROL-NM EPITHELIA, AND NOTABLY, WE HAVE DEMONSTRATED FOR THE FIRST TIME THAT GENETIC TRANSCRIPTIONAL PROGRAM RESPONSIBLE OF CILIOGENESIS AND CILIA FUNCTION IS SIGNIFICANTLY IMPAIRED IN CRSWNP EPITHELIUM, PRESUMABLY PRODUCED BY AN ALTERED EXPRESSION OF MICRORNAS, PARTICULARLY OF THOSE MIRS BELONGING TO MIR-34 AND MI-449 FAMILIES. CONCLUSIONS: THIS STUDY PROVIDES FOR THE FIRST TIME A NOVEL INSIGHT INTO THE MOLECULAR BASIS OF SINONASAL MUCOCILIARY DIFFERENTIATION, DEMONSTRATING THAT TRANSCRIPTOME RELATED TO CILIOGENESIS AND CILIA FUNCTION IS SIGNIFICANTLY IMPAIRED DURING DIFFERENTIATION OF CRSWNP EPITHELIUM DUE TO AN ALTERED EXPRESSION OF MICRORNAS. 2020 9 5086 40 PILOT STUDY OF DNA METHYLATION IN THE PATHOGENESIS OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. BACKGROUND: DNA METHYLATION HAS BEEN IMPLICATED IN THE PATHOGENESIS OF ALLERGY AND ATOPY. THIS STUDY AIMED TO IDENTIFY WHETHER DNA METHYLATION ALSO PLAYS AN IMPORTANT ROLE IN THE PATHOGENESIS OF NASAL POLYPS (NP). METHODOLOGY: NP TISSUES WERE OBTAINED FROM 32 PATIENTS WITH CHRONIC RHINOSINUSITIS WITH BILATERAL NP. BIOPSIES OF INFERIOR TURBINATE MUCOSA (ITM) WERE TAKEN FROM 18 PATIENTS WHO UNDERWENT RHINOSEPTOPLASTY (CONTROL GROUP). THE METHYLATED GENES, WHICH WERE DETECTED BY DNA METHYLATION MICROARRAY, WERE VALIDATED BY METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION, BISULPHITE SEQUENCING, REAL-TIME POLYMERASE CHAIN REACTION AND IMMUNOHISTOCHEMISTRY. RESULTS: DNA METHYLATION MICROARRAY IDENTIFIED 8,008 CPG ISLANDS IN 2,848 GENES. ONE HUNDRED AND NINETY-EIGHT GENES WERE FOUND TO HAVE A METHYLATED SIGNAL IN THE PROMOTER REGION IN NP SAMPLES COMPARED WITH ITM SAMPLES. THE FOUR TOP GENES THAT CHANGED, COL18A1, EP300, GNAS AND SMURF1, WERE SELECTED FOR FURTHER STUDY. THE METHYLATION FREQUENCY OF COL18A1 WAS SIGNIFICANTLY HIGHER IN NP SAMPLES THAN IN ITM SAMPLES. CONCLUSIONS: DNA METHYLATION MIGHT PLAY AN IMPORTANT ROLE IN THE PATHOGENESIS OF NP. PROMOTER METHYLATION OF COL18A1 WAS FOUND TO BE SIGNIFICANTLY INCREASED IN NP TISSUES, FURTHER STUDIES ARE NECESSARY TO CONFIRM THE SIGNIFICANCE OF THESE EPIGENETIC FACTORS IN THE MECHANISMS UNDERLYING THE DEVELOPMENT OR PERSISTENCE OF NP. 2015 10 2349 37 EPIGENETIC REGULATION OF MYOFIBROBLAST DIFFERENTIATION AND EXTRACELLULAR MATRIX PRODUCTION IN NASAL POLYP-DERIVED FIBROBLASTS. BACKGROUND: NASAL POLYPOSIS IS A MULTI-FACTORIAL DISEASE ASSOCIATED WITH CHRONIC INFLAMMATORY CONDITION OF THE PARANASAL SINUSES. MYOFIBROBLAST DIFFERENTIATION AND EXTRACELLULAR MATRIX (ECM) ACCUMULATION ARE INVOLVED IN THE PATHOGENESIS OF NASAL POLYPOSIS. OBJECTIVE: THE AIM OF THIS STUDY WAS TO STUDY THE EFFECT OF TRICHOSTATIN A (TSA), A HISTONE DEACETYLASE (HDAC) INHIBITOR, ON TRANSFORMING GROWTH FACTOR (TGF)-BETA1-INDUCED MYOFIBROBLAST DIFFERENTIATION AND ECM ACCUMULATION IN NASAL POLYP-DERIVED FIBROBLASTS (NPDFS). METHODS: NASAL POLYP-DERIVED FIBROBLASTS WERE ISOLATED FROM NASAL POLYPS OF PATIENTS WHO HAVE CHRONIC RHINOSINUSITIS WITH NASAL POLYP. TSA WAS TREATED IN TGF-BETA1-INDUCED NPDFS. EXPRESSION LEVELS OF HDAC2, ALPHA-SMOOTH MUSCLE ACTIN (SMA), TGF-BETA1, COLLAGEN TYPE I, ACETYLATED HISTONE H3, ACETYLATED HISTONE H4, PHOSPHORYLATED SMAD2/3 AND SMAD7 WERE DETERMINED BY RT-PCR, WESTERN BLOT AND/OR IMMUNOFLUORESCENT STAINING. THE TOTAL COLLAGEN AMOUNT PRODUCTION WAS ANALYSED BY SIRCOL SOLUBLE COLLAGEN ASSAY AND CONTRACTILE ACTIVITY WAS MEASURED BY COLLAGEN GEL CONTRACTION ASSAY. HDAC2 INHIBITION BY TSA OR HDAC2 SILENCING WAS ESTABLISHED BY RT-PCR AND WESTERN BLOT. THE EPIGENETIC EFFECT ON ALPHA-SMA GENE INACTIVATION WAS EXAMINED BY CHROMATIN IMMUNOPRECIPITATION ASSAY. PROLIFERATION WAS DETERMINED BY KI67-POSITIVE CELL STAINING AND CYTOTOXICITY WAS ASSESSED BY 3-(4,5- DIMETHYLTHIAZOL-2YL)-2,5-DIPHENYL-2H-TETRAZOLIUM BROMIDE (MTT) ASSAY. RESULTS: THE EXPRESSION LEVELS OF HDAC2, ALPHA-SMA AND TGF-BETA1 WERE INCREASED IN NASAL POLYP TISSUES COMPARED TO NORMAL INFERIOR TURBINATE TISSUES. TSA AND HDAC2 SILENCING INHIBITED EXPRESSION LEVELS ALPHA-SMA, COLLAGEN AND HDAC2. TSA INDUCED HYPERACETYLATION OF HISTONE AND SUPPRESSED OPENING OF ALPHA-SMA GENE PROMOTER IN TGF-BETA1-INDUCED NPDFS. TSA INHIBITED TGF-BETA1-INDUCED SMAD 2/3 AND RESCUED TGF-BETA1-SUPPRESSED SMAD7 SIGNALLING PATHWAY. FINALLY, TSA BLOCKED PROLIFERATION IN TGF-BETA1-INDUCED NPDFS AND HAS NO CYTOTOXIC EFFECT IN NPDFS. CONCLUSIONS AND CLINICAL RELEVANCE: THESE RESULTS SUGGEST THAT HDAC INHIBITION IS ASSOCIATED WITH MYOFIBROBLAST DIFFERENTIATION AND EXTRACELLUAR MATRIX ACCUMULATION IN NASAL POLYPOSIS. TSA MAY BE USEFUL AS AN INHIBITOR OF NASAL POLYP GROWTH, AND THUS HAS POTENTIAL TO BE USED AS A NOVEL TREATMENT OPTION FOR NASAL POLYPOSIS. 2012 11 3524 45 IL-13 REGULATES HUMAN NASAL EPITHELIAL CELL DIFFERENTIATION VIA H3K4ME3 MODIFICATION. INTRODUCTION: EPIGENETIC REGULATION HAS BEEN SHOWN TO PLAY AN IMPORTANT ROLE IN THE DEVELOPMENT OF INFLAMMATORY DISEASES, INCLUDING CHRONIC RHINOSINUSITIS AND NASAL POLYPS. THE LATTER ARE CHARACTERIZED BY EPITHELIAL MIS-DIFFERENTIATION AND INFILTRATION OF INFLAMMATORY CYTOKINES. H3K4ME3 HAS BEEN SHOWN TO BE INVOLVED IN REGULATING LINEAGE COMMITMENT. HOWEVER, THE UNDERLYING MECHANISMS, ESPECIALLY IN HUMAN NASAL EPITHELIAL CELLS (HNEPC), REMAIN UNDEREXPLORED. THE OBJECTIVE OF THIS STUDY WAS TO INVESTIGATE THE ROLE OF H3K4ME3 IN HNEPC DIFFERENTIATION TREATED WITH THE TH2 CYTOKINE IL-13. PATIENTS AND METHODS: THE EXPRESSION LEVELS OF MRNA AND PROTEINS WERE INVESTIGATED USING REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-PCR) ASSAYS AND WESTERN BLOT IN NASAL POLYP TISSUES AND HUMAN NASAL EPITHELIAL CELLS RESPECTIVELY. WE MEASURED THESE LEVELS OF H3K4ME3, MLL1 AND TARGETED GENES COMPARED WITH CONTROL SUBJECTS. RESULTS: WE DEMONSTRATE THAT EXPRESSION OF H3K4ME3 AND ITS METHYLTRANSFERASE MLL1 WAS SIGNIFICANTLY UPREGULATED IN IL-13-TREATED HNEPC. THIS ELEVATION WAS ALSO OBSERVED IN NASAL POLYPS. EXPRESSION OF CILIA-RELATED TRANSCRIPTION FACTORS FOXJ1 AND DNAI2 DECREASED, WHILE GOBLET CELL-DERIVED GENES CLCA1 AND MUC5A INCREASED UPON IL-13 TREATMENT. MECHANISTICALLY, KNOCKDOWN OF MLL1 RESTORED EXPRESSION OF THESE FOUR GENES INDUCED BY IL-13. CONCLUSION: THESE FINDINGS SUGGEST THAT H3K4ME3 IS A CRITICAL REGULATOR IN CONTROL OF NASAL EPITHELIAL CELL DIFFERENTIATION. MLL1 MAY BE A POTENTIAL THERAPEUTIC TARGET FOR NASAL INFLAMMATORY DISEASES. 2017 12 1826 33 EFFECTS OF HISTONE DEACETYLASE INHIBITOR ON EXTRACELLULAR MATRIX PRODUCTION IN HUMAN NASAL POLYP ORGAN CULTURES. BACKGROUND: NASAL POLYPOSIS IS ASSOCIATED WITH A CHRONIC INFLAMMATORY CONDITION OF THE SINONASAL MUCOSA AND INVOLVES MYOFIBROBLAST DIFFERENTIATION AND EXTRACELLULAR MATRIX (ECM) ACCUMULATION. EPIGENETIC MODULATION BY HISTONE DEACETYLASE (HDAC) INHIBITORS INCLUDING TRICHOSTATIN A (TSA) HAS BEEN REPORTED TO HAVE INHIBITORY EFFECTS ON MYOFIBROBLAST DIFFERENTIATION IN LUNG AND RENAL FIBROBLASTS. THE PURPOSE OF THIS STUDY WAS TO INVESTIGATE THE INHIBITORY EFFECT OF TSA ON MYOFIBROBLAST DIFFERENTIATION AND ECM PRODUCTION IN NASAL POLYP ORGAN CULTURES. METHODS: NASAL POLYP TISSUES FROM 18 PATIENTS WERE ACQUIRED DURING ENDOSCOPIC SINUS SURGERY. AFTER ORGAN CULTURE, NASAL POLYPS WERE STIMULATED WITH TGF-BETA1 AND THEN TREATED WITH TSA. ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA), FIBRONECTIN, AND COLLAGEN TYPE I EXPRESSION LEVELS WERE EXAMINED BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (PCR), REAL-TIME PCR, WESTERN BLOT, AND IMMUNOFLUORESCENT STAINING. HDAC2, HDAC4, AND ACETYLATED H4 EXPRESSION LEVELS WERE ASSAYED BY WESTERN BLOT. CYTOTOXICITY WAS ANALYZED BY THE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE BIOTIN-DUTP NICK END LABELING ASSAY. RESULTS: THE EXPRESSION LEVELS OF ALPHA-SMA, FIBRONECTIN, AND COLLAGEN TYPE 1 WERE INCREASED IN NASAL POLYP AFTER TRANSFORMING GROWTH FACTOR (TGF) BETA1 TREATMENT. TSA-INHIBITED TGF-BETA1 INDUCED THESE GENE AND PROTEIN EXPRESSION LEVELS. FURTHERMORE, TSA SUPPRESSED PROTEIN EXPRESSION LEVELS OF HDAC2 AND HDAC4. HOWEVER, TSA INDUCED HYPERACETYLATION OF HISTONES H4. TREATMENT WITH TGF-BETA1 WITH OR WITHOUT TSA DID NOT HAVE CYTOTOXIC EFFECT. CONCLUSION: THESE FINDINGS PROVIDE NOVEL INSIGHTS INTO THE EPIGENETIC REGULATION IN MYOFIBROBLAST DIFFERENTIATION AND ECM PRODUCTION OF NASAL POLYP. TSA COULD BE A CANDIDATE OF A THERAPEUTIC AGENT FOR REVERSING THE TGF-BETA1-INDUCED ECM SYNTHESIS THAT LEADS TO NASAL POLYP DEVELOPMENT. 2013 13 3019 31 GENETICS AND EPIGENETICS OF NASAL POLYPOSIS: A SYSTEMATIC REVIEW. CHRONIC RHINOSINUSITIS (CRS) IS AN INFLAMMATORY DISEASE OF THE NOSE AND PARANASAL SINUSES THAT IS OFTEN ASSOCIATED WITH NASAL POLYPOSIS (CRSWNP) IN THE MOST SEVERE CASES. AS IN OTHER COMPLEX DISEASES, GENETIC FACTORS ARE THOUGHT TO PLAY AN IMPORTANT ROLE IN THE RISK AND DEVELOPMENT OF THE DISEASE. ENVIRONMENT MAY ALSO MODULATE THE EPIGENETIC SIGNATURE IN AFFECTED PATIENTS. IN THE PRESENT SYSTEMATIC REVIEW, WE AIMED TO COMPILE ALL PUBLISHED DATA ON GENETIC AND EPIGENETIC VARIATIONS IN CRSWNP SINCE 2000. WE FOUND 104 ARTICLES, 24 OF WHICH WERE RELATED TO EPIGENETIC STUDIES. WE IDENTIFIED MORE THAN 150 GENETIC VARIANTS IN 99 GENES INVOLVED IN THE PATHOGENESIS OF NASAL POLYPOSIS. THESE WERE CLUSTERED INTO 8 MAIN NETWORKS, LINKING GENES INVOLVED IN INFLAMMATION AND IMMUNE RESPONSE (EG, MHC), CYTOKINE GENES (EG, TNF), LEUKOTRIENE METABOLISM, AND THE EXTRACELLULAR MATRIX. A TOTAL OF 89 MIRNAS WERE ALSO IDENTIFIED; THESE ARE ASSOCIATED MAINLY WITH BIOLOGICAL FUNCTIONS SUCH AS THE CELL CYCLE, INFLAMMATION, AND THE IMMUNE RESPONSE. WE PROPOSE A POTENTIAL RELATIONSHIP BETWEEN GENES AND THE MIRNAS IDENTIFIED THAT MAY OPEN NEW LINES OF INVESTIGATION. AN IN-DEPTH KNOWLEDGE OF GENE VARIANTS AND EPIGENETIC TRAITS COULD HELP US TO DESIGN MORE TAILORED TREATMENT FOR PATIENTS WITH CRSWNP. 2021 14 3746 38 INSIGHTS INTO THE EPIGENETICS OF CHRONIC RHINOSINUSITIS WITH AND WITHOUT NASAL POLYPS: A SYSTEMATIC REVIEW. BACKGROUND: EPIGENETICS FACILITATES INSIGHTS ON THE IMPACT OF HOST ENVIRONMENT ON THE GENESIS OF CHRONIC RHINOSINUSITIS (CRS) THROUGH MODULATIONS OF HOST GENE EXPRESSION AND ACTIVITY. EPIGENETIC MECHANISMS SUCH AS DNA METHYLATION CAUSE REVERSIBLE BUT HERITABLE CHANGES IN GENE EXPRESSION OVER GENERATIONS OF PROGENY, WITHOUT ALTERING THE DNA BASE-PAIR SEQUENCES. THESE STUDIES OFFER A CRITICAL UNDERSTANDING OF THE ENVIRONMENT-INDUCED CHANGES THAT RESULT IN HOST PREDISPOSITION TO DISEASE AND MAY HELP IN DEVELOPING NOVEL BIOMARKERS AND THERAPEUTICS. THE GOAL OF THIS SYSTEMATIC REVIEW IS TO SUMMARIZE THE CURRENT EVIDENCE ON EPIGENETICS OF CRS WITH A FOCUS ON CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) AND HIGHLIGHT GAPS THAT MERIT FURTHER RESEARCH. METHODS: A SYSTEMATIC REVIEW OF THE ENGLISH LANGUAGE LITERATURE WAS PERFORMED TO IDENTIFY INVESTIGATIONS RELATED TO EPIGENETIC STUDIES IN SUBJECTS WITH CRS. RESULTS: THE REVIEW IDENTIFIED 65 STUDIES. THESE HAVE FOCUSED ON DNA METHYLATION AND NON-CODING RNAS, WITH ONLY A FEW ON HISTONE DEACETYLATION, ALTERNATIVE POLYADENYLATION, AND CHROMATIN ACCESSIBILITY. STUDIES INCLUDE THOSE INVESTIGATING IN VIVO AND IN VITRO CHANGES OR BOTH. STUDIES ALSO INCLUDE ANIMAL MODELS OF CRS. ALMOST ALL HAVE BEEN CONDUCTED IN ASIA. THE GENOME-WIDE STUDIES OF DNA METHYLATION FOUND DIFFERENCES IN GLOBAL METHYLATION BETWEEN CRSWNP AND CONTROLS, WHILE OTHERS SPECIFICALLY FOUND SIGNIFICANT DIFFERENCES IN METHYLATION OF THE CPG SITES OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP), IL-8, AND PLAT. IN ADDITION, DNA METHYLTRANSFERASE INHIBITORS AND HISTONE DEACETYLASE INHIBITORS WERE STUDIED AS POTENTIAL THERAPEUTIC AGENTS. MAJORITY OF THE STUDIES INVESTIGATING NON-CODING RNAS FOCUSED ON MICRO-RNAS (MIRNA) AND FOUND DIFFERENCES IN GLOBAL EXPRESSION OF MIRNA LEVELS. THESE STUDIES ALSO REVEALED SOME PREVIOUSLY KNOWN AS WELL AS NOVEL TARGETS AND PATHWAYS SUCH AS TUMOR NECROSIS FACTOR ALPHA, TGF BETA-1, IL-10, EGR2, ARYL HYDROCARBON RECEPTOR, PI3K/AKT PATHWAY, MUCIN SECRETION, AND VASCULAR PERMEABILITY. OVERALL, THE STUDIES HAVE FOUND A DYSREGULATION IN PATHWAYS/GENES INVOLVING INFLAMMATION, IMMUNE REGULATION, TISSUE REMODELING, STRUCTURAL PROTEINS, MUCIN SECRETION, ARACHIDONIC ACID METABOLISM, AND TRANSCRIPTION. CONCLUSIONS: EPIGENETIC STUDIES IN CRS SUBJECTS SUGGEST THAT THERE IS LIKELY A MAJOR IMPACT OF THE ENVIRONMENT. HOWEVER, THESE ARE ASSOCIATION STUDIES AND DO NOT DIRECTLY IMPLY PATHOGENESIS. LONGITUDINAL STUDIES IN GEOGRAPHICALLY AND RACIALLY DIVERSE POPULATION COHORTS ARE NECESSARY TO QUANTIFY GENETIC VS. ENVIRONMENTAL RISKS FOR CRSWNP AND CRS WITHOUT NASAL POLYPS AND ASSESS HERITABILITY RISK, AS WELL AS DEVELOP NOVEL BIOMARKERS AND THERAPEUTIC AGENTS. 2023 15 1632 35 DNMTS ARE INVOLVED IN TGF-BETA1-INDUCED EPITHELIAL-MESENCHYMAL TRANSITIONS IN AIRWAY EPITHELIAL CELLS. CHRONIC RHINOSINUSITIS (CRS) PATHOGENESIS IS CLOSELY RELATED TO TISSUE REMODELING, INCLUDING EPITHELIAL-MESENCHYMAL TRANSITION (EMT). EPIGENETIC MECHANISMS PLAY KEY ROLES IN EMT. DNA METHYLATION, MEDIATED BY DNA METHYLTRANSFERASES (DNMTS), IS AN EPIGENETIC MARKER THAT IS CRITICAL TO EMT. THE GOAL OF THIS STUDY WAS TO DETERMINE WHETHER DNMTS WERE INVOLVED IN TGF-BETA1-INDUCED EMT AND ELUCIDATE THE UNDERLYING MECHANISMS IN NASAL EPITHELIAL CELLS AND AIR-LIQUID INTERFACE CULTURES. GLOBAL DNA METHYLATION AND DNMT ACTIVITY WERE QUANTIFIED. DNMT EXPRESSION WAS MEASURED USING REAL-TIME PCR (QRT-PCR) IN HUMAN CRS TISSUES. MRNA AND PROTEIN LEVELS OF DNMTS, E-CADHERIN, VIMENTIN, ALPHA-SMA, AND FIBRONECTIN WERE DETERMINED USING RT-PCR AND WESTERN BLOTTING, RESPECTIVELY. DNMT1, DNMT3A, AND DNMT3B GENE EXPRESSION WERE KNOCKED DOWN USING SIRNA TRANSFECTION. MAPK PHOSPHORYLATION AND EMT-RELATED TRANSCRIPTION FACTOR LEVELS WERE DETERMINED USING WESTERN BLOTTING. SIGNALING PATHWAYS WERE ANALYZED USING SPECIFIC INHIBITORS OF MAPK. WE DEMONSTRATED THESE DATA IN PRIMARY NASAL EPITHELIAL CELLS AND AIR-LIQUID INTERFACE CULTURES. GLOBAL DNA METHYLATION, DNMT ACTIVITY, AND DNMT EXPRESSION INCREASED IN CRS TISSUES. DNMT EXPRESSION WAS POSITIVELY CORRELATED WITH LUND-MCKAY CT SCORES. TGF-BETA1 DOSE-DEPENDENTLY INDUCED DNMT EXPRESSION. FURTHER, 5-AZA INHIBITED TGF-BETA1-INDUCED DNMT, SNAIL, AND SLUG EXPRESSION RELATED TO EMT, AS WELL AS P38 AND JNK PHOSPHORYLATION IN A549 CELLS AND TGF-BETA1-INDUCED DNMT EXPRESSION AND EMT IN PRIMARY NASAL EPITHELIAL CELLS AND AIR-LIQUID INTERFACE CULTURES. TGF-BETA1-INDUCED DNMT EXPRESSION LEADS TO DNA METHYLATION AND EMT VIA P38, JNK, SNAIL, AND SLUG SIGNALING PATHWAYS. INHIBITION OF DNMT SUPPRESSED THE EMT PROCESS AND THEREFORE IS POTENTIALLY A CRS THERAPEUTIC STRATEGY. 2022 16 3014 27 GENETICS AND EPIGENETICS OF CHRONIC RHINOSINUSITIS. DISCERNING THE GENETICS AND EPIGENETICS OF CHRONIC RHINOSINUSITIS (CRS) MAY OPTIMIZE OUTCOMES THROUGH EARLY DIAGNOSTICS, PERSONALIZED AND NOVEL THERAPEUTICS, AND EARLY PROGNOSTICATION. CRS ASSOCIATED WITH CYSTIC FIBROSIS AND PRIMARY CILIARY DYSKINESIA HAS WELL-CHARACTERIZED GENETIC MUTATIONS. MOST CRS SUBJECTS, HOWEVER, DO NOT EXHIBIT IDENTIFIABLE MONOGENIC ALTERATIONS. CLUSTERING IN RELATED INDIVIDUALS IS SEEN IN CRS WITH NASAL POLYPS. SPOUSES OF SUBJECTS WITH CRS WITHOUT NASAL POLYPS ALSO MAY BE AT INCREASED RISK OF THE SAME DISEASE. THESE OBSERVATIONS GENERATE QUESTIONS ON GENETIC AND ENVIRONMENTAL INFLUENCES IN CRS. GENOME-WIDE ASSOCIATION STUDIES HAVE IDENTIFIED VARIATIONS AND POLYMORPHISMS BETWEEN CRS AND CONTROL SUBJECTS IN GENES RELATED TO INNATE AND ADAPTIVE IMMUNITY. CANDIDATE GENE AND TRANSCRIPTOMICS STUDIES HAVE INVESTIGATED AND IDENTIFIED GENETIC VARIATIONS RELATED TO IMMUNITY, INFLAMMATION, EPITHELIAL BARRIER FUNCTION, STRESS-RESPONSE, ANTIGEN PROCESSING, T-CELL REGULATION, AND CYTOKINES IN CRS. EPIGENETIC STUDIES HAVE IDENTIFIED MECHANISMS THROUGH WHICH ENVIRONMENTAL FACTORS MAY AFFECT THESE GENE FUNCTIONS. HOWEVER, CAUSALITY IS NOT DETERMINED FOR MOST VARIATIONS. INFERENCES DRAWN FROM THESE DATA MUST BE MEASURED BECAUSE MOST INVESTIGATIONS REPORT UNREPLICATED RESULTS FROM SMALL STUDY POPULATIONS. LARGE, REPLICATED STUDIES IN TIGHT COHORTS ACROSS DIVERSE POPULATIONS REMAIN A PRESSING NEED IN STUDYING CRS GENETICS. 2023 17 2217 21 EPIGENETIC MODIFICATIONS IN CHRONIC RHINOSINUSITIS WITH AND WITHOUT NASAL POLYPS. CHRONIC RHINOSINUSITIS (CRS) HAS BROUGHT A HUGE SOCIOECONOMIC BURDEN. HOWEVER, ITS MECHANISM IS STILL ELUSIVE, WHICH MAY INVOLVE GENETIC, ENVIRONMENTAL AND SOME OTHER FACTORS. EPIGENETIC ANALYSES HAVE BEEN CONDUCTED TO EXPLORE THE MECHANISMS UNDERLYING CRS. HERE, WE REVIEWED THE FRUITS IN THE EPIGENETIC STUDIES ON DNA METHYLATION, HISTONE MODIFICATION, AND NON-CODING RNA REGULATION. WE CONCLUDED THAT THE EPIGENETIC RESEARCH ON CRS HAS MADE GREAT BREAKTHROUGHS, ESPECIALLY IN THE PAST 5 YEARS AND THE FIELD OF MICRORNAS. "EPIGENETIC THERAPIES" ARE EXPECTED TO BE DESIGNED TO TREAT CRS IN THE FUTURE. 2022 18 3976 28 LONG-TERM DEFECTS OF NASAL EPITHELIUM BARRIER FUNCTIONS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA POST CHEMO-RADIOTHERAPY. BACKGROUND AND PURPOSE: CHRONIC AND RECURRENT UPPER RESPIRATORY TRACT INFECTION AND INFLAMMATION IS COMMON IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA (NPC) POST CHEMO-RADIOTHERAPY (CRT). WHETHER IT IS DUE TO INTRINSIC (E.G., HOST-DEFENSE MECHANISMS OF THE EPITHELIUM), EPIGENETIC OR EXTRINSIC FACTORS IS NOT FULLY UNDERSTOOD. MATERIALS AND METHODS: TISSUE BIOPSIES OF THE MIDDLE TURBINATE (MT) AND INFERIOR TURBINATE (IT) FROM NPC PATIENTS AFTER CRT (MEAN OF 3 YEARS, N = 39) WERE COMPARED WITH THE IT BIOPSIES FROM HEALTHY SUBJECTS (N = 44). THE EPITHELIAL ULTRASTRUCTURE WAS EXAMINED BY TRANSMISSION ELECTRON MICROSCOPE (TEM). MRNA AND PROTEIN EXPRESSIONS OF EPITHELIAL STEM/PROGENITOR CELLS MARKERS, AS WELL MARKERS OF CELL PROLIFERATION AND DIFFERENTIATION MARKERS WAS ANALYZED. RESULTS: ABNORMAL EPITHELIAL ARCHITECTURE WAS OBSERVED IN ALL TISSUE SAMPLES OF NPC PATIENTS. SIGNIFICANTLY DECREASED EXPRESSION LEVELS OF MRNA AND PROTEIN LEVELS FOR P63 (BASAL CELLS), KI67 (CELL PROLIFERATION), P63(+)/KRT5(+) (EPITHELIAL STEM/PROGENITOR CELLS), MUC5AC AND MUC5B (SECRETARY PROTEINS FROM GOBLET CELLS), ALPHA-TUBULIN, BETA-TUBULIN AND TAP73 (CILIATED CELLS), DNAH5 AND DNAI1 AND RSPH4A (MICROTUBULE ASSEMBLIES OF MOTILE CILIA), FOXJ1 AND CP110 (CILIOGENESIS-ASSOCIATED MARKERS) WERE EVIDENT IN MT AND IT BIOPSIES FROM NPC PATIENTS WHEN COMPARED TO HEALTHY CONTROLS. CONCLUSION: CRT CAUSES LONG-TERM DEFECTS OF EPITHELIAL BARRIER FUNCTIONS AND INCREASES THE SUSCEPTIBILITY OF THESE PATIENTS TO UPPER RESPIRATORY TRACT INFECTION AND INFLAMMATION. 2020 19 327 34 ALLERGIC INFLAMMATORY MEMORY IN HUMAN RESPIRATORY EPITHELIAL PROGENITOR CELLS. BARRIER TISSUE DYSFUNCTION IS A FUNDAMENTAL FEATURE OF CHRONIC HUMAN INFLAMMATORY DISEASES(1). SPECIALIZED SUBSETS OF EPITHELIAL CELLS-INCLUDING SECRETORY AND CILIATED CELLS-DIFFERENTIATE FROM BASAL STEM CELLS TO COLLECTIVELY PROTECT THE UPPER AIRWAY(2-4). ALLERGIC INFLAMMATION CAN DEVELOP FROM PERSISTENT ACTIVATION(5) OF TYPE 2 IMMUNITY(6) IN THE UPPER AIRWAY, RESULTING IN CHRONIC RHINOSINUSITIS, WHICH RANGES IN SEVERITY FROM RHINITIS TO SEVERE NASAL POLYPS(7). BASAL CELL HYPERPLASIA IS A HALLMARK OF SEVERE DISEASE(7-9), BUT IT IS NOT KNOWN HOW THESE PROGENITOR CELLS(2,10,11) CONTRIBUTE TO CLINICAL PRESENTATION AND BARRIER TISSUE DYSFUNCTION IN HUMANS. HERE WE PROFILE PRIMARY HUMAN SURGICAL CHRONIC RHINOSINUSITIS SAMPLES (18,036 CELLS, N = 12) THAT SPAN THE DISEASE SPECTRUM USING SEQ-WELL FOR MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING(12), REPORT TRANSCRIPTOMES FOR HUMAN RESPIRATORY EPITHELIAL, IMMUNE AND STROMAL CELL TYPES AND SUBSETS FROM A TYPE 2 INFLAMMATORY DISEASE, AND MAP KEY MEDIATORS. BY COMPARISON WITH NASAL SCRAPINGS (18,704 CELLS, N = 9), WE DEFINE SIGNATURES OF CORE, HEALTHY, INFLAMED AND POLYP SECRETORY CELLS. WE REVEAL MARKED DIFFERENCES BETWEEN THE EPITHELIAL COMPARTMENTS OF THE NON-POLYP AND POLYP CELLULAR ECOSYSTEMS, IDENTIFYING AND VALIDATING A GLOBAL REDUCTION IN CELLULAR DIVERSITY OF POLYPS CHARACTERIZED BY BASAL CELL HYPERPLASIA, CONCOMITANT DECREASES IN GLANDULAR CELLS, AND PHENOTYPIC SHIFTS IN SECRETORY CELL ANTIMICROBIAL EXPRESSION. WE DETECT AN ABERRANT BASAL PROGENITOR DIFFERENTIATION TRAJECTORY IN POLYPS, AND PROPOSE CELL-INTRINSIC(13), EPIGENETIC(14,15) AND EXTRINSIC FACTORS(11,16,17) THAT LOCK POLYP BASAL CELLS INTO THIS UNCOMMITTED STATE. FINALLY, WE FUNCTIONALLY DEMONSTRATE THAT EX VIVO CULTURED BASAL CELLS RETAIN INTRINSIC MEMORY OF IL-4/IL-13 EXPOSURE, AND TEST THE POTENTIAL FOR CLINICAL BLOCKADE OF THE IL-4 RECEPTOR ALPHA-SUBUNIT TO MODIFY BASAL AND SECRETORY CELL STATES IN VIVO. OVERALL, WE FIND THAT REDUCED EPITHELIAL DIVERSITY STEMMING FROM FUNCTIONAL SHIFTS IN BASAL CELLS IS A KEY CHARACTERISTIC OF TYPE 2 IMMUNE-MEDIATED BARRIER TISSUE DYSFUNCTION. OUR RESULTS DEMONSTRATE THAT EPITHELIAL STEM CELLS MAY CONTRIBUTE TO THE PERSISTENCE OF HUMAN DISEASE BY SERVING AS REPOSITORIES FOR ALLERGIC MEMORIES. 2018 20 5610 35 S100A4/TCF COMPLEX TRANSCRIPTION REGULATION DRIVES EPITHELIAL-MESENCHYMAL TRANSITION IN CHRONIC SINUSITIS THROUGH WNT/GSK-3BETA/BETA-CATENIN SIGNALING. EPITHELIAL-MESENCHYMAL TRANSITION (EMT) IS THOUGHT TO BE INVOLVED IN THE TISSUE REMODELING AND LONG-TERM INFLAMMATORY PROCESS OF CHRONIC SINUSITIS (CRS), BUT THE DRIVING MECHANISM IS STILL UNCLEAR. USING HIGH-RESOLUTION MASS SPECTROMETRY, WE PERFORMED A PROTEOMIC SCREEN OF CRS NASAL MUCOSAL TISSUE TO IDENTIFY DIFFERENTIALLY EXPRESSED PROTEINS. DATA ARE AVAILABLE VIA PROTEOMEXCHANGE WITH IDENTIFIER PXD030884. SPECIFICALLY, WE IDENTIFIED S100 CALCIUM BINDING PROTEIN A4 (S100A4), AN EFFECTIVE FACTOR IN INFLAMMATION-RELATED DISEASES, AND ITS DOWNSTREAM PROTEIN CLOSELY RELATED TO TISSUE FIBROSIS COLLAGEN TYPE I ALPHA 1 CHAIN (COL1A1), WHICH SUGGESTED ITS INVOLVEMENT IN NASAL MUCOSAL TISSUE REMODELING. IN ADDITION, STIMULATION OF HUMAN NASAL EPITHELIAL CELLS (HNEPCS) WITH LIPOPOLYSACCHARIDE (LPS) MIMICKED THE INFLAMMATORY ENVIRONMENT OF CRS AND SHOWED THAT S100A4 IS INVOLVED IN REGULATING EMT AND THUS ACCELERATING TISSUE REMODELING IN THE NASAL MUCOSA, BOTH IN TERMS OF INCREASED CELL MOTILITY AND OVEREXPRESSION OF MESENCHYMAL-TYPE PROTEINS. ADDITIONALLY, WE FURTHER INVESTIGATED THE REGULATION MECHANISM OF S100A4 INVOLVED IN EMT IN CRS. OUR RESEARCH RESULTS SHOW THAT IN THE INFLAMMATORY ENVIRONMENT OF CRS NASAL MUCOSAL EPITHELIAL CELLS, TCF-4 WILL TARGET TO BIND TO S100A4 AND REGULATE ITS TRANSCRIPTION. THE TRANSCRIPTION OF S100A4 IN TURN AFFECTS THE EXECUTION OF THE IMPORTANT SIGNALING PATHWAY IN EMT, THE WNT/GSK-3BETA/BETA-CATENIN PATHWAY, THROUGH THE TCF-4/BETA-CATENIN COMPLEX. IN CONCLUSION, THIS STUDY CONFIRMED THAT THE EXPRESSION OF S100A4 WAS SIGNIFICANTLY INCREASED DURING THE PROGRESSIVE EMT PROCESS OF CRS MUCOSAL EPITHELIAL CELLS, AND REVEALED THAT THE TRANSCRIPTIONAL REGULATION OF S100A4 PLAYS AN IMPORTANT ROLE IN THE OCCURRENCE AND DEVELOPMENT OF EMT. THIS FINDING WILL HELP US TO BETTER UNDERSTAND THE PATHOGENESIS BEHIND THE REMODELING IN CRS PATIENTS, AND IDENTIFY TARGET MOLECULES FOR THE TREATMENT OF CRS. 2022